Tailor-made Pharma Solutions l Pharma Intelligence

Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Commercial Success

Clinical Planning

Patient Engagement & Recruitment

Regulatory & Compliance

Conferences 2022

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Tailor-made solutions

Use the expertise and experience of Pharma Intelligence to produce custom solutions that are actionable, flexible, and tailored to help you successfully navigate biopharma portfolio management, commercial optimization, and R&D strategy. Benefit from:

A customized approach – we develop solutions to fit your situation
Joint problem/opportunity definition
Proprietary data and complementary market research
The experience of 500+ industry experts
Collaborative problem solving
Fact-based decisions and actionable recommendations
Ownership of final decisions and action plans

Discover new business opportunities, reduce risks, and make better, faster decisions with tailor-made pharmaceutical solutions from Pharma Intelligence.

TrialScope Atlas

TrialScope Atlas

19 May 2022

Clinical trial disclosure is a complex process driven by a constantly evolving collection of registry rules and health authority regulations.

Topic Regulation

View white paper
Citeline Connect, Trialtrove

Clinical Trials Day

17 May 2022

Topic Clinical Trials

View white paper
TrialScope Disclose

Clinical trial disclosure experts provide an overview of EU CTR/CTIS regulations and timelines for compliance

13 May 2022

Clinical trial disclosure experts Francine Lane and Thomas Wicks provide an overview of EU CTR/CTIS regulations and timelines for compliance.

Topic Market Intelligence

Full video
What Does The Pharma Industry Want From CDMOs?

13 May 2022

Based on a survey to over 100 of pharma’s senior decision makers, find out what organizations really want from CDMOs.

Business Strategies Leadership

View infographic
Pharma 360

Global Oncology Opportunities & Trends 2025: Key Markets, Indications and Product

13 May 2022

Join Informa Pharma Intelligence for the “Global Oncology Opportunities” webinar!

View article
TrialScope Disclose

Disclosure & transparency experts discuss the ins and outs of CTIS

13 May 2022

Disclosure & transparency experts from Sarepta, Boehringer Ingelheim, Bayer and Merck KGaA discuss the ins and outs of CTIS.

Topic Regulation

Full video
Citeline, Pharmaprojects

Navigate the landscape in our Pharma R&D Annual Review 2022

By Ian Lloyd 14 Apr 2022

Our world was disrupted at warp speed during 2020. Are you ready to gain a deeper understanding of the year that changed our perceptions of possible?

Topic Clinical Trials Diseases Drug Review

View white paper
Chemist + Druggist Data

New pip codes for Northern Ireland and Great Britain

11 Mar 2022

We are pleased to announce that from mid-February 2022, C+D Data will provide the UK supply chain with additional product listings and associated PIP-codes for Northern Ireland (NI) and Great Britain (GB.) This solution will allow you to reach the entire UK market quickly and facilitate the ordering and distribution of medicines without disruption to you, and your wholesalers – while ensuring the data’s accuracy, visibility, and long-term management.

View article
In Vivo

Outlook 2022: What Next for Pharma After a Year of Innovation and Growth?

02 Mar 2022

Look ahead with our Pharma Outlook 2022 Extract as we discuss what's coming up in the biopharma space.

Single report
Citeline

Integrate your data to get the full picture

01 Mar 2022

View article
Biomedtracker, Meddevicetracker

Don’t miss your free extract of Early 2022 Outlook Report

08 Feb 2022

In pharma’s fast paced and continually evolving world, accurately anticipating the impact of events on the horizon is critical to your success.

Topic Business Strategies

Single report
TrialScope Disclose

Clinical Trial Transparency Policy

07 Feb 2022

Disclosure requirements are numerous and ever evolving. Study sponsors need a transparency policy that addresses disclosure, transparency, and data sharing.

Topic Policy & Regulation

View white paper
Citeline

Rare Disease Trial Strategies

02 Feb 2022

In our rare disease trial strategies whitepaper, see which sponsors lead the way, understand the geographical location of trials, and delve into the types of therapeutic area, plus much more.

Topic Rare Diseases

View white paper
Pink Sheet

Accelerated Approval Makes Big Splash In 2021 Novel Agents, Despite Crackdown On ‘Dangling’ Cancer Claims

By Bridget Silverman 19 Jan 2022

US FDA’s accelerated approvals hit a contemporary high in 2021, accounting for one-third of novel US approvals, but the big story was the agency’s crackdown on delinquent confirmatory trials for oncology AA indications.

View article
Pink Sheet

Care Needed With Plain Language Summaries Of EU Study Results

By Vibha Sharma 18 Jan 2022

The EU will make it mandatory for clinical trial sponsors to prepare layperson summaries of their study results. Industry practices around content presentation, translation and dissemination of these documents will be keenly watched.

View article

Latest headlines

Scrip

23 May 2022

Zymeworks Rejects ‘Opportunistic’ Investor Takeover Bid

Link
Generics Bulletin

23 May 2022

Stada And Calliditas Celebrate European Nod For Budesonide Hybrid

Link
Medtech Insight

23 May 2022

European Regulatory Roundup, May 2022: IVDR Applies And MDR Critics Clamor Loudly For Action

Link
In Vivo

23 May 2022

How Can Pharma Seek To Discuss Gender Diversity?

Link
In Vivo

23 May 2022

Microbot Medical Hopes To Bring First Disposable Endovascular Robot To US Market

Link
In Vivo

23 May 2022

COVID-19 Gives US Biopharma Plenty Of Q1 Cover

Link
Scrip

23 May 2022

Sanofi Closes In On A Pair Of Approval Firsts

Link
HBW Insight

23 May 2022

France Reverse-Switches Muscle Relaxant Methocarbamol

Link
Medtech Insight

23 May 2022

EU MedTech Forum 2022: Regulatory Unpredictability Spurs Renewed Calls For Devices Agency

Link
Scrip

23 May 2022

Dr Reddy’s Pressing On In Russia, China Approvals Add Spark

Link
Medtech Insight

23 May 2022

Philips, Hamilton Medical To FDA: QMSR Shouldn’t Subject Devices To ISO Traceability Requirements

Link
Scrip

23 May 2022

Korean Biopharmas Rush To Boston: What Are The Challenges And Opportunities?

Link
Pink Sheet

23 May 2022

ERC Not Giving Up On Glioma Immunotherapy In EU

Link
Pink Sheet

23 May 2022

Philippines Considers Regulatory Reliance To Speed Up Evaluating Trial Applications

Link
Pink Sheet

23 May 2022

NGOs Praise C-TAP COVID-19 Deals But Say Much More Needs To Be Done

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Speak to Sales

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact Sales

Client Services

US Toll-Free : +1 888 670 8900
US Toll : +1 212-600-3520
UK & Europe : +44 (0) 208 052 0700

Contact Customer Services

Pharma Report Store

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now

Tailor-made Pharma Solutions

Tailor-made solutions

Pharma Intelligence latest insights

TrialScope Atlas

Clinical Trials Day

Clinical trial disclosure experts provide an overview of EU CTR/CTIS regulations and timelines for compliance

What Does The Pharma Industry Want From CDMOs?

Global Oncology Opportunities & Trends 2025: Key Markets, Indications and Product

Disclosure & transparency experts discuss the ins and outs of CTIS

Navigate the landscape in our Pharma R&D Annual Review 2022

New pip codes for Northern Ireland and Great Britain

Outlook 2022: What Next for Pharma After a Year of Innovation and Growth?

Integrate your data to get the full picture

Don’t miss your free extract of Early 2022 Outlook Report

Clinical Trial Transparency Policy

Rare Disease Trial Strategies

Accelerated Approval Makes Big Splash In 2021 Novel Agents, Despite Crackdown On ‘Dangling’ Cancer Claims

Care Needed With Plain Language Summaries Of EU Study Results

Latest headlines

Zymeworks Rejects ‘Opportunistic’ Investor Takeover Bid

Stada And Calliditas Celebrate European Nod For Budesonide Hybrid

European Regulatory Roundup, May 2022: IVDR Applies And MDR Critics Clamor Loudly For Action

How Can Pharma Seek To Discuss Gender Diversity?

Microbot Medical Hopes To Bring First Disposable Endovascular Robot To US Market

COVID-19 Gives US Biopharma Plenty Of Q1 Cover

Sanofi Closes In On A Pair Of Approval Firsts

France Reverse-Switches Muscle Relaxant Methocarbamol

EU MedTech Forum 2022: Regulatory Unpredictability Spurs Renewed Calls For Devices Agency

Dr Reddy’s Pressing On In Russia, China Approvals Add Spark

Philips, Hamilton Medical To FDA: QMSR Shouldn’t Subject Devices To ISO Traceability Requirements

Korean Biopharmas Rush To Boston: What Are The Challenges And Opportunities?

ERC Not Giving Up On Glioma Immunotherapy In EU

Philippines Considers Regulatory Reliance To Speed Up Evaluating Trial Applications

NGOs Praise C-TAP COVID-19 Deals But Say Much More Needs To Be Done

Next steps

This is Contactus Section

Request a live demo

Speak to Sales

Client Services

Pharma Report Store